Phase I Study to Determine the Maximum Tolerable Dose of BAY94-9343 in Patients With Advanced Solid Tumors.
Clinical trial NCT01439152 · COMPLETED
Trial details
- NCT number
- NCT01439152
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-07
- Primary completion
- 2016-12-31
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.